Developed Markets include primarily North America and Europe.
Greater China includes China, Taiwan and Hong Kong.
JANZ reflects operations in Japan, Australia and New Zealand.
Emerging Markets encompass operations in countries with developing markets and emerging economies including countries in Asia, the
Middle East, South and Central America, Africa and Eastern Europe, and also includes the company’s anti-retroviral franchise.
In 2025, Viatris reported net sales of ***Â billion U.S. dollars in developed markets, compared to *** billion U.S. dollars in 2022. Viatris is a global healthcare company headquartered in the United States, with centers in Pennsylvania, Shanghai, and Hyderabad, India. The company was formed in November 2020 through the combination of Mylan and the Upjohn Business (owned by Pfizer Inc.). Its global portfolio comprises more than approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized iconic brands (such as Viagra, Xanax, Lipitor).
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Viatris, & U.S. Securities and Exchange Commission. (February 26, 2026). Viatris' net sales from 2022 to 2025, by market (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 29, 2026, from /statistics/1234934/viatris-net-sales-by-regional-market/
Viatris, und U.S. Securities and Exchange Commission. "Viatris' net sales from 2022 to 2025, by market (in million U.S. dollars) ." Chart. February 26, 2026. ÌÇÐÄÆƽâ°æ. Accessed July 29, 2026. /statistics/1234934/viatris-net-sales-by-regional-market/
Viatris, U.S. Securities and Exchange Commission. (2026). Viatris' net sales from 2022 to 2025, by market (in million U.S. dollars) . ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 29, 2026. /statistics/1234934/viatris-net-sales-by-regional-market/
Viatris, and U.S. Securities and Exchange Commission. "Viatris' Net Sales from 2022 to 2025, by Market (in Million U.S. Dollars) ." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 26 Feb 2026, /statistics/1234934/viatris-net-sales-by-regional-market/
Viatris & U.S. Securities and Exchange Commission, Viatris' net sales from 2022 to 2025, by market (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1234934/viatris-net-sales-by-regional-market/ (last visited July 29, 2026)
Viatris' net sales from 2022 to 2025, by market (in million U.S. dollars) [Graph], Viatris, & U.S. Securities and Exchange Commission, February 26, 2026. [Online]. Available: /statistics/1234934/viatris-net-sales-by-regional-market/
